Long-term glycaemic effects of pioglitazone compared with placebo as add-on treatment to metformin or sulphonylurea monotherapy in PROactive (PROactive 18). (Q43225402)

From Wikidata
Jump to navigation Jump to search
scientific article published in December 2009
edit
Language Label Description Also known as
English
Long-term glycaemic effects of pioglitazone compared with placebo as add-on treatment to metformin or sulphonylurea monotherapy in PROactive (PROactive 18).
scientific article published in December 2009

    Statements

    Long-term glycaemic effects of pioglitazone compared with placebo as add-on treatment to metformin or sulphonylurea monotherapy in PROactive (PROactive 18). (English)
    A J Scheen
    D J Betteridge
    K Birkeland
    O Schmitz
    B Charbonnel
    PROactive investigators
    1 December 2009
    1242-1249

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit